Picture of Cynata Therapeutics logo

CYP — Cynata Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Cynata Advances Planned Clinical Trial In Diabetic Foot Ulcers In MoU With Tekcyte

March 1 (Reuters) - Cynata Therapeutics Ltd  CYP.AX :
    * CYNATA ADVANCES PLANNED CLINICAL TRIAL IN DIABETIC FOOT
ULCERS
IN MOU WITH TEKCYTE
    * CYNATA THERAPEUTICS LTD - PLANS TO UNDERTAKE CLINICAL
TRIAL OF
ITS CYMERUS MSC PRODUCT  BASED ON PRE-CLINICAL FOUNDATION,
UTILISING TEKCYTE TECHNOLOGY
    * CYNATA THERAPEUTICS LTD - TEKCYTE WILL WORK WITH CYNATA TO
MANUFACTURE AND SUPPLY ACTIVE DRESSING FOR PLANNED CLINICAL
TRIAL

Source text for Eikon:  ID:nGNX13chxc 
Further company coverage:  CYP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cynata Therapeutics

See all news